Literature DB >> 2202302

Multiple protein forms of the human breast tumor-associated epithelial membrane antigen (EMA) are generated by alternative splicing and induced by hormonal stimulation.

C J Williams1, D H Wreschner, A Tanaka, I Tsarfaty, I Keydar, A S Dion.   

Abstract

Cloning and sequencing of epithelial membrane antigen (EMA) has demonstrated the existence of a variable number of tandem repeats (VNTR) flanked by unique sequences, and alternative splicing has been proposed to result in secreted and membrane-bound antigenic forms. Antisense oligonucleotides, specific for the VNTR region and various alternative splice forms, were used as probes to define EMA transcripts in poly A+ RNA from a mucinous breast tumor cell line. The BT549 line has been shown to exhibit enhanced expression and secretion of EMA when the cells are cultivated in a medium supplemented with hydrocortisone and insulin, and Northern blot analysis demonstrated that EMA-related RNA transcripts are commensurately enhanced. As a result of the large increase in EMA RNA levels, two major transcripts in BT549 have been identified as coding for either the secreted or transmembrane EMA forms and two antigenic forms have been immunoprecipitated from BT549 cell layer and medium translation products.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2202302     DOI: 10.1016/0006-291x(90)90540-4

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Expression of the human MUC1 mucin cDNA in a hamster pancreatic tumor cell line HP-1.

Authors:  S K Batra; R S Metzgar; A J Worlock; M A Hollingsworth
Journal:  Int J Pancreatol       Date:  1992-12

2.  MUC1 expressed in PanC1 cells decreases adhesion to type 1 collagen but increases contraction in collagen lattices.

Authors:  M J Hudson; G W Stamp; M A Hollingsworth; M Pignatelli; E N Lalani
Journal:  Am J Pathol       Date:  1996-03       Impact factor: 4.307

3.  Sialyl-Lewis x and Sialyl-Lewis a are associated with MUC1 in human endometrium.

Authors:  N A Hey; J D Aplin
Journal:  Glycoconj J       Date:  1996-10       Impact factor: 2.916

4.  Immunodiscrimination of colorectal neoplasia using MUC1 antibodies: discrepant findings in tissue versus stool.

Authors:  P J Limburg; D A Ahlquist; J A Gilbert; J J Harrington; G G Klee; P C Roche
Journal:  Dig Dis Sci       Date:  2000-03       Impact factor: 3.199

5.  Protein multifunctionality: principles and mechanisms.

Authors:  Joseph Z Zaretsky; Daniel H Wreschner
Journal:  Transl Oncogenomics       Date:  2008-05-15

Review 6.  Mucin-Microbiota Interaction During Postnatal Maturation of the Intestinal Ecosystem: Clinical Implications.

Authors:  Sana Rokhsefat; Aifeng Lin; Elena M Comelli
Journal:  Dig Dis Sci       Date:  2016-01-20       Impact factor: 3.199

7.  Epithelial membrane antigen expression in breast fluids and 'witch's milk'.

Authors:  C J Williams; A S Dion; J Carten; G C Buehring
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

8.  Sialomucin complex at the rat ocular surface: a new model for ocular surface protection.

Authors:  S A Price-Schiavi; D Meller; X Jing; J Merritt; M E Carvajal; S C Tseng; K L Carraway
Journal:  Biochem J       Date:  1998-10-15       Impact factor: 3.857

Review 9.  MUC1, the renaissance molecule.

Authors:  S J Gendler
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-07       Impact factor: 2.698

10.  MUC1 expression and anti-MUC1 serum immune response in head and neck squamous cell carcinoma (HNSCC): a multivariate analysis.

Authors:  Martín E Rabassa; María V Croce; Adrián Pereyra; Amada Segal-Eiras
Journal:  BMC Cancer       Date:  2006-10-25       Impact factor: 4.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.